Cargando…
Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs
CONTEXT: Patients with non-alcoholic steatohepatitis (NASH) may have a simultaneous intake of pravastatin and evodiamine-containing herbs. OBJECTIVE: The effect of evodiamine on the pharmacokinetics of pravastatin and its potential mechanisms were investigated in NASH rats. MATERIALS AND METHODS: Th...
Autores principales: | Liang, Ruifeng, Ge, Wenjing, Li, Bingjie, Cui, Weifeng, Ma, Xiaofan, Pan, Yuying, Li, Gengsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856114/ https://www.ncbi.nlm.nih.gov/pubmed/35171063 http://dx.doi.org/10.1080/13880209.2022.2036767 |
Ejemplares similares
-
3012 Functional consequences of pravastatin isomerization on OATP1B1-mediated transport
por: Wagner, Jonathan, et al.
Publicado: (2019) -
Vitamin D Deficiency Impacts Exposure and Response of Pravastatin in Male Rats by Altering Hepatic OATPs
por: Peng, Jinfu, et al.
Publicado: (2022) -
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling
por: Mao, Jialin, et al.
Publicado: (2018) -
Evaluation of the Cardiotoxicity of Evodiamine In Vitro and In Vivo
por: Yang, Weifeng, et al.
Publicado: (2017) -
Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives
por: Hu, Xu, et al.
Publicado: (2018)